Abstract
Microfluidic platform for the synthesis of complex nanocapsules is presented via a controlled self-assembly. The monodisperse nanocapsules in the range of 50-200 nm consist of a dendritic polyethylene core and a Pluronic copolymer shell. The resultant nanocarriers encapsulate large amount of hydrophobic anticancer drug like paclitaxel while providing a low complement activation as well as sustained release profile with high tunability.
| Original language | English |
|---|---|
| Pages (from-to) | 3118-3123 |
| Number of pages | 6 |
| Journal | Advanced Materials |
| Volume | 26 |
| Issue number | 19 |
| DOIs | |
| State | Published - 21 May 2014 |
| Externally published | Yes |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Keywords
- cancer therapeutics
- controlled drug delivery
- hyperbranched polyethylene nanocapsule
- microfluidic-assisted self-assembly
- paclitaxel
ASJC Scopus subject areas
- General Materials Science
- Mechanics of Materials
- Mechanical Engineering
Fingerprint
Dive into the research topics of 'Microfluidic-assisted self-assembly of complex dendritic polyethylene drug delivery nanocapsules'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver